Document is current
Any future updates will be listed below
-
Authors
Li, Daniel Y. https://orcid.org/0000-0003-1015-6298
Kundu, Soumya https://orcid.org/0000-0001-5182-5326
Cheng, Paul https://orcid.org/0000-0003-3429-2702
Gu, Wenduo https://orcid.org/0000-0002-3859-3150
Worssam, Matthew D. https://orcid.org/0000-0003-4391-5377
Jackson, William R.
Zhao, Quanyi https://orcid.org/0000-0001-9849-4528
Nguyen, Trieu https://orcid.org/0000-0001-5647-1301
Yu, Amelia M.
Monteiro, João P. https://orcid.org/0000-0001-6481-6875
Caceres, Roxanne D.
Dale, Stanley
Palmisano, Brian T.
Weldy, Chad S. https://orcid.org/0000-0003-4652-6422
Ramste, Markus https://orcid.org/0000-0003-4048-4591
Kundu, Ramendra
Kundaje, Anshul https://orcid.org/0000-0003-3084-2287
Wirka, Robert C.
Quertermous, Thomas https://orcid.org/0000-0002-7645-9067
- License Information
-
More Information
Article History
Received: 18 June 2025
Accepted: 2 March 2026
First Online: 17 March 2026
Competing interests
: T.Q. is on the scientific advisory board of Amgen. A.K. is a scientific co-founder Immunera; on the scientific advisory board of SerImmune, TensorBio; is a consultant with Bristol Myers Squibb, Arcardia Science, Inari, Precede Biosciences; and has a financial stake in DeepGenomics, Immunai, SerImmune, Freenome, Immunera and TensorBio. The remaining authors declare no competing interests.
